drugset / Trial / NCT03313297
Glucocorticoids and Skin Healing in Diabetes (GC-SHealD)
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The study aims to investigate effects of inhibiting glucocorticoid activation on skin function and wound healing in patients with type 2 diabetes. Half of patients will be given a drug to inhibit glucocorticoid activation and the other half will be given a placebo.
Timeline
- Start
- 2018-04-10
- Primary completion
- 2019-02-27
- Completion
- 2019-03-13
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | AZD4017 | Small molecule | 400 mg | Oral |